Is Telomere Length Shortening a Risk Factor for Neurodegenerative Disorders?

키워드

참고문헌 (54)

1. Hou Y, "Ageing as a risk factor for neurodegenerative disease", Nat Rev Neurol, 15, pp.565~581 (2019)
2. Azam S, "The ageing brain : molecular and cellular basis of neurodegeneration", Front Cell Dev Biol, 9, pp.683459~ (2021)
3. Bernadotte A, "Markers of cellular senescence. Telomere shortening as a marker of cellular senescence", Aging(Albany NY), 8, pp.3~11 (2016)
4. Wright WE, "Normal human chromosomes have long G-rich telomeric overhangs at one end", Genes Dev, 11, pp.2801~2809 (1997)
5. McEachern MJ, "Telomeres and their control", Annu Rev Genet, 34, pp.331~358 (2000)
6. Sarek G, "CDK phosphorylation of TRF2 controls t-loop dynamics during the cell cycle", Nature, 575, pp.523~527 (2019)
7. Koh SH, "Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease", Aging(Albany NY), 12, pp.4407~4423 (2020)
8. Wang J, "Potential roles of telomeres and telomerase in neurodegenerative diseases", Int J Biol Macromol, 163, pp.1060~1078 (2020)
9. Kim EJ, "Increased telomere length in patients with frontotemporal dementia syndrome", J Neurol Sci, 428, pp.117565~ (2021)
10. Fani L, "Telomere length and the risk of Alzheimer’s disease : the Rotterdam Study", J Alzheimers Dis, 73, pp.707~714 (2020)
11. Chow HM, "Genomic integrity and the ageing brain", Nat Rev Neurosci, 16, pp.672~684 (2015)
12. Møller P, "Genotoxicity of environmental agents assessed by the alkaline comet assay", Basic Clin Pharmacol Toxicol, 96(Suppl 1), pp.1~42 (2005)
13. Jeppesen DK, "DNA repair deficiency in neurodegeneration", Prog Neurobiol, 94, pp.166~200 (2011)
14. McKinnon PJ, "Maintaining genome stability in the nervous system", Nat Neurosci, 16, pp.1523~1529 (2013)
15. Hwang JY, "The emerging field of epigenetics in neurodegeneration and neuroprotection", Nat Rev Neurosci, 18, pp.347~361 (2017)
16. López-Otín C, "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
17. Johri A, "Mitochondrial dysfunction in neurodegenerative diseases", J Pharmacol Exp Ther, 342, pp.619~630 (2012)
18. Keogh MJ, "Mitochondrial DNA mutations in neurodegeneration", Biochim Biophys Acta, 1847, pp.1401~1411 (2015)
19. Kültz D, "Molecular and evolutionary basis of the cellular stress response", Annu Rev Physiol, 67, pp.225~257 (2005)
20. Kuilman T, "The essence of senescence", Genes Dev, 24, pp.2463~2479 (2010)
21. Narita M, "Spatial coupling of mTOR and autophagy augments secretory phenotypes", Science, 332, pp.966~970 (2011)
22. Oh J, "Stem cell aging : mechanisms, regulators and therapeutic opportunities", Nat Med, 20, pp.870~880 (2014)
23. Currais A, "Ageing and inflammation-A central role for mitochondria in brain health and disease", Ageing Res Rev, 21, pp.30~42 (2015)
24. Shin JS, "The role of telomeres and telomerase in the pathology of human cancer and aging", Pathology, 38, pp.103~113 (2006)
25. van Steensel B, "TRF2 protects human telomeres from end-to-end fusions", Cell, 92, pp.401~413 (1998)
26. Takubo K, "Telomere shortening with aging in human liver", J Gerontol A Biol Sci Med Sci, 55, pp.B533~B536 (2000)
27. Herrmann M, "Telomere biology and age-related diseases", Clin Chem Lab Med, 56, pp.1210~1222 (2018)
28. Cawthon RM, "Association between telomere length in blood and mortality in people aged 60 years or older", Lancet, 361, pp.393~395 (2003)
29. Lukens JN, "Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer’s disease", Alzheimers Dement, 5, pp.463~469 (2009)
30. Panossian LA, "Telomere shortening in T cells correlates with Alzheimer’s disease status", Neurobiol Aging, 24, pp.77~84 (2003)
31. Scarabino D, "Leukocyte telomere length in mild cognitive impairment and Alzheimer’s disease patients", Exp Gerontol, 98, pp.143~147 (2017)
32. Lee EH, "Relationship between telomere shortening and age in Korean individuals with mild cognitive impairment and Alzheimer’s disease compared to that in healthy controls", Aging(Albany NY), 13, pp.2089~2100 (2020)
33. Liu M, "Telomere shortening in Alzheimer’s disease patients", Ann Clin Lab Sci, 46, pp.260~265 (2016)
34. Hackenhaar FS, "Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers", Alzheimers Res Ther, 13, pp.130~ (2021)
35. Palmos AB, "Telomere length and human hippocampal neurogenesis", Neuropsychopharmacology, 45, pp.2239~2247 (2020)
36. Ashrafi A, "Leukocyte telomere length is unrelated to cognitive performance among non-demented and demented persons : an examination of long life family study participants", J Int Neuropsychol Soc, 26, pp.906~917 (2020)
37. Zekry D, "Telomere length is not predictive of dementia or MCI conversion in the oldest old", Neurobiol Aging, 31, pp.719~720 (2010)
38. Rolyan H, "Telomere shortening reduces Alzheimer’s disease amyloid pathology in mice", Brain, 134, pp.2044~2056 (2011)
39. Lee A, "Epidemiology of Parkinson disease", Neurol Clin, 34, pp.955~965 (2016)
40. Simon DK, "Parkinson disease epidemiology, pathology, genetics, and pathophysiology", Clin Geriatr Med, 36, pp.1~12 (2020)
41. Martin-Ruiz C, "Senescence and inflammatory markers for predicting clinical progression in Parkinson’s disease : the ICICLE-PD study", J Parkinsons Dis, 10, pp.193~206 (2020)
42. Wu Y, "Accelerated telomere shortening independent of LRRK2 variants in Chinese patients with Parkinson’s disease", Aging(Albany NY), 12, pp.20483~20492 (2020)
43. Levstek T, "Assessment of the telomere length and its effect on the symptomatology of Parkinson’s disease", Antioxidants, 10, pp.137~ (2021)
44. Degerman S, "Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism", PLoS One, 9, pp.e113387~ (2014)
45. Schürks M, "Telomere length and Parkinson’s disease in men : a nested case-control study", Eur J Neurol, 21, pp.93~99 (2014)
46. Wang H, "Telomere length and risk of Parkinson’s disease", Mov Disord, 23, pp.302~305 (2008)
47. Hudson G, "No evidence of substantia nigra telomere shortening in Parkinson's disease", Neurobiol Aging, 32, pp.2107.e3~2107.e5 (2011)
48. Forero DA, "Telomere length in Parkinson’s disease : a meta-analysis", Exp Gerontol, 75, pp.53~55 (2016)
49. Khan BK, "Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion", J Neurol Neurosurg Psychiatry, 83, pp.358~364 (2012)
50. Strong MJ, "Amyotrophic lateral sclerosis-frontotemporal spectrum disorder(ALS-FTSD) : revised diagnostic criteria", Amyotroph Lateral Scler Frontotemporal Degener, 18, pp.153~174 (2017)
51. Linkus B, "Telomere shortening leads to earlier age of onset in ALS mice", Aging(Albany NY), 8, pp.382~393 (2016)
52. De Felice B, "Telomerase expression in amyotrophic lateral sclerosis(ALS)patients", J Hum Genet, 59, pp.555~561 (2014)
53. Al Khleifat A, "Telomere length is greater in ALS than in controls : a whole genome sequencing study", Amyotroph Lateral Scler Frontotemporal Degener, 20, pp.229~234 (2019)
54. Xia K, "Leukocyte telomere length and amyotrophic lateral sclerosis : a Mendelian randomization study", Orphanet J Rare Dis, 16, pp.508~ (2021)

관련 논문AI추천